Home/Pipeline/Depression Clinical Trials

Depression Clinical Trials

Depression

Not Applicable (Service)Active

Key Facts

Indication

Depression

Phase

Not Applicable (Service)

Status

Active

Company

IMA Clinical Research

About IMA Clinical Research

IMA Clinical Research is a private, revenue-generating clinical research services company with a nationwide network of over 15 full-service sites and 150+ satellite locations. Its business model is centered on providing clinical trial execution services to pharmaceutical sponsors and CROs, leveraging a large patient database and a flexible, decentralized operational model to accelerate enrollment. The company is actively recruiting for trials in key therapeutic areas including metabolic-liver disease (MASH), neurology (memory loss), psychiatry (depression), and obesity, indicating a focus on high-prevalence chronic conditions.

View full company profile

Therapeutic Areas

Metabolic Disease (MASH)Neurology (Memory Loss)Psychiatry (Depression)Obesity

Other Depression Drugs

Drug	Company	Phase	Status
Undisclosed Programs	johnson-and-johnson-innovative-medicine	Pipeline	Active
Depression Study	Sun Valley Research Center	Not Disclosed	Active
eTNS Platform	NeuroSigma	Unknown	Active
ALM003	Almatica Pharma	Phase 3	Active
ALM014	Almatica Pharma	Pivotal BA/BE	Active
NRCT-101SR	Neurocentria	Phase 2b/3	Active
Starstim for Depression	Neuroelectrics	Phase 1/2	Active
Depression Biomarkers	Paradise Genomics	Discovery	Active
Home-tDCS Depression Trial	Soterix Medical	N/A (Device-enabled trial)	Active
BPL-003	AtaiBeckley	Phase 2	Active
VLS-01	AtaiBeckley	Phase 2	Active
NC-2800	Nippon Chemiphar	Phase 2a	Active - Patient enrollment started as of Jan 2026